Archive

Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics

Development of Antibody-Drug Conjugates in Immuno-Oncology

Licensing Deal for Lead Drug in South Korea

Agreement with Nipro Corporation for iCertainty Imaging Technology

Development and Commercialization of Ublituximab